Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Sign In to gain access to subscriptions and/or personal tools.
Medical Decision Making
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Sismanidis, C.
Right arrow Articles by Poloniecki, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sismanidis, C.
Right arrow Articles by Poloniecki, J.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Properties of the Cumulative Risk-Adjusted Mortality (CRAM) Chart, Including the Number of Deaths Before a Doubling of the Death Rate is Detected

Charalambos Sismanidis

Martin Bland

Jan Poloniecki

The cumulative risk-adjusted mortality (CRAM) chart is intended to detect changes in the failure rate in a sequence of trials when the relative risk but not the absolute risk of failure at each trial is known. For example, surgical mortality can be monitored taking into account the heterogeneity of patients and procedures. We simulate abrupt change to twice or half the previous failure rate and series with no change. As with any control procedure, changes are eventually signaled whether or not real changes have occurred. With initial mean failure rates ranging from 1% to 25%, the median number of failures before a doubling is signaled is about 20 (i.e., about 10 extra failures) and is nearly independent of the extent of heterogeneity in the series. CRAM chart calculations give an estimate of the risk of failure at the next trial, and we document the performance of this estimate.

Key Words: quality control chart properties • hospital deaths • risk assessment

Medical Decision Making, Vol. 23, No. 3, 242-251 (2003)
DOI: 10.1177/0272989X03023003006
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Eur. J. Cardiothorac. Surg.Home page
N. Kang, V. T. Tsang, S. Gallivan, C. Sherlaw-Johnson, T. J. Cole, M. J. Elliott, and M. R. de Leval
Quality assurance in congenital heart surgery.
Eur. J. Cardiothorac. Surg., May 1, 2006; 29(5): 693 - 697.
[Abstract] [Full Text] [PDF]